International researchers have recently developed a method for capturing blood cells to isolate tumors, using a novel liquid biopsy device that functions as a 3D printed cell trap.
This technique is being used in research for cancer treatment as an improved way to target cancer cells which can be difficult to find (and often to allow for a diagnosis)'”as well as monitoring for the further spreading of cancer cells if they metastasize.
To put it into perspective, it is important to understand that the few cancer cells being sought could be hidden in billions of other blood cells. The 3D printed trap finds these cells as white blood cells are kept in, and red blood cells are filtered back out. While previous methods have been used, in most cases they lack efficiency and damage cells in the trap.
'œCapturing these tumor cells is in itself a big challenge,' says researcher Fatih Sarioglu. 'œBecause there are billions of blood cells, you need an engineering tool, a technology that can screen the cells one by one. You cannot miss even one cell. Typical lab techniques don't work.'
'œThe other problem is that cancer cells constantly mutate, so you can't rely on one type of marker to distinguish them from the other cells, even from blood cells, and they can sometimes hide very efficiently between the blood cells.'
Made up of 32 microfluidic layers, the cell trap measures 100 mm x 20.5 mm x 19.2 mm and is fully detailed in the recently published '˜Hybrid negative enrichment of circulating tumor cells from whole blood in a 3D-printed monolithic device', featuring Chia-Heng Chu as the lead author.
The device functions with two different sections: a multi-layered immunoaffinity-based leukocyte capture section and a filtration section, with the design created in SolidWorks and then 3D printed on a ProJet 3510 HD 3D printer with VisiJet ® M3-X plastic material. Device size was restricted due to the size of the centrifugation tube required for dewaxing.
3D printing allowed for the more streamlined fabrication of the device, especially due to the potential for a larger surface area; however, the technology also presented a major issue in the need to eliminate the solid wax used as a necessary '˜sacrificial filler.'
'œWe tried a bunch of different ways using traditional medical tools in bio labs and ended up with a standard centrifuge that removes the hard wax by heating the trap and spinning it to extract the then liquid wax from the channels,' said Sarioglu. 'œThat was a manufacturing challenge that we had to work on.'
Simulated samples were created as they '˜spiked' tumor cells into whole blood, mainly culturing Ovarian cancer cell line HeyA8, human breast cancer cell line MDA-MB-231 (ATCC ® HTB-26) and prostate cancer cell line LNCaP (ATCC ® CRL-1740).
Post-filtration of the '˜leuko-depleted blood' made it possible for the researchers to maintain all the nucleated cells'”even leftover WBCs that were on the detachable membrane filter. Overall, the team sees the potential for further advancement and even better performance in their scalable technique.
'œThis is what I am living for in a way: You spend time to think of something, work hard to realize it, and at the end you see it working with the idea that it will help people,' said Sarioglu. 'œThat's why I made the transition from just building sensitive tools and engineering devices to things that can help people and impact their lives.'
A variety of 3D printing devices are being used these days for diagnostics and treatment of cancer, along with training devices like 3D printed phantoms. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: '˜Capturing Blood Cells to Isolate Tumor Cells'; Hybrid negative enrichment of circulating tumor cells from whole blood in a 3D-printed monolithic device']